Biology Reference
In-Depth Information
19. Peter ME (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer
progression. Cell Cycle 8(6):843-852
20. Trang P et al (2010) Regression of murine lung tumors by the let-7 microRNA. Oncogene
29(11):1580-1587
21. Bonci D et al (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting
multiple oncogenic activities. Nat Med 14(11):1271-1277
22. Finnerty JR et al (2010) The miR-15/107 group of microRNA genes: evolutionary biology,
cellular functions, and roles in human diseases. J Mol Biol 402(3):491-509
23. Lu J et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):
834-838
24. Bottoni A et al (2005) miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell
Physiol 204(1):280-285
25. Yanaihara N et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell 9(3):189-198
26. Volinia S et al (2006) A microRNA expression signature of human solid tumors defines can-
cer gene targets. Proc Natl Acad Sci USA 103(7):2257-2261
27. Pichiorri F et al (2008) MicroRNAs regulate critical genes associated with multiple myeloma
pathogenesis. Proc Natl Acad Sci USA 105(35):12885-12890
28. Poliseno L et al (2010) Identification of the miR-106b 25 microRNA cluster as a proto-
oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transforma-
tion. Sci Signal 3(117):ra29
29. Uziel T et al (2009) The miR-17 92 cluster collaborates with the Sonic Hedgehog pathway in
medulloblastoma. Proc Natl Acad Sci USA 106(8):2812-2817
30. Mendell JT (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell
133(2):217-222
31. Xiao C et al (2008) Lymphoproliferative disease and autoimmunity in mice with increased
miR-17-92 expression in lymphocytes. Nat Immunol 9(4):405-414
32. Calin GA et al (2005) A MicroRNA signature associated with prognosis and progression in
chronic lymphocytic leukemia. N Engl J Med 353(17):1793-1801
33. Garzon R et al (2008) MicroRNA signatures associated with cytogenetics and prognosis in
acute myeloid leukemia. Blood 111(6):3183-3189
34. Garzon R et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing
cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105(10):3945-3950
35. Ciafre SA et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun 334(4):1351-1358
36. Jazbutyte V, Thum T (2010) MicroRNA-21: from cancer to cardiovascular disease. Curr
Drug Targets 11(8):926-935
37. Meng F et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene
in human hepatocellular cancer. Gastroenterology 133(2):647-658
38. Frankel LB et al (2008) Programmed cell death 4 (PDCD4) is an important functional target
of the microRNA miR-21 in breast cancer cells. J Biol Chem 283(2):1026-1033
39. Zhu S et al (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).
J Biol Chem 282(19):14328-14336
40. Pekarsky Y et al (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by
miR-29 and miR-181. Cancer Res 66(24):11590-11593
41. Zhao JJ et al (2010) microRNA expression profile and identification of miR-29 as a prognos-
tic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood
115(13):2630-2639
42. Xiong Y et al (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of
hepatocellular carcinoma. Hepatology 51(3):836-845
43. Mott JL et al (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene
26(42):6133-6140
44. Lujambio A et al (2008) A microRNA DNA methylation signature for human cancer metas-
tasis. Proc Natl Acad Sci USA 105(36):13556-13561
Search WWH ::
Custom Search